Monitoring blood clotting in hemophilia using sound technology
Official title: Coagulation Monitoring in Hemophilia via Acoustic Tweezing Spectroscopy
Funded at Levisonics, INC. · NIH-10922338 · Data updated 2026-11-12
This study is exploring a new way to check how well your blood clots using a tiny drop of blood, which could make it easier and more accurate for people with hemophilia to manage their treatment.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Levisonics, INC. NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | June 1, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $299,309 |
| NIH project number | 1R43HL174341-01 |
| Project ID | NIH-10922338 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have been diagnosed with hemophilia or other bleeding disorders.
✕Less likely to help
Patients who do not have bleeding disorders or coagulation issues may not benefit from this research.
What this research studies
This research investigates a new method for monitoring blood coagulation in patients with hemophilia using a technology called acoustic tweezing spectroscopy. By utilizing a small drop of blood, the method can measure various stages of coagulation simultaneously, providing comprehensive insights into a patient's coagulation status. This approach aims to improve the convenience and accuracy of coagulation monitoring, which is crucial for effective treatment management. The technology could potentially replace existing coagulation tests that are less effective for modern hemophilia therapies.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and convenient monitoring of blood coagulation, improving treatment outcomes for hemophilia patients.
How similar studies have gone: While the use of acoustic tweezing for coagulation monitoring is a novel approach, similar technologies have shown promise in other medical applications, indicating potential for success.
Where this research is happening
-
Levisonics, INC.
New Orleans, United States Active
Researchers
- Principal investigator: Kasireddy, Nithya — Levisonics, INC.
- Study coordinator: Kasireddy, Nithya
Related research
Other NIH-funded projects on the same topics.
-
cGMP production of FVIII-making placental cells to help people with Hemophilia A
A new, patient-friendly therapy aims to make FVIII-producing placental cells in the lab to help adults with Hemophilia A, potentially offering a longer-lasting and more affordable treatment.
-
Enhancing immune regulation in gene therapy for hemophilia (new approaches to safer treatment)
A patient-focused overview of a long-running NIH grant exploring how to make gene therapy for hemophilia safer by teaching the body’s immune system to tolerate the therapeutic protein.
-
A safer, longer-lasting gene delivery approach for Hemophilia A using improved nonviral vectors
Researchers are testing a new type of nonviral gene delivery that could provide longer expression of a therapeutic gene for adults with Hemophilia A.
-
Non-viral gene therapy approach to permanently fix hemophilia B
A new gene therapy approach aims to permanently correct hemophilia B without using viruses, potentially reducing bleeding events for people with this condition.
-
Hemophilia Point-of-Care Test Gets Regulatory Ready
A new point-of-care test for hemophilia A measures FVIII and emicizumab to help doctors manage bleeding risk quickly, with plans to obtain regulatory clearance.
-
Hemophilia A: studying why some people develop inhibitors to FVIII across families
This NIH grant funds a multi-year program to follow families affected by severe hemophilia A to understand why some individuals develop antibodies against factor VIII.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.